4934.T
Premier Anti-Aging Co.,Ltd.
グロース · 化学 · 素材・化学 · JP
JPY 598.00
−0.66%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 15.6B | 16.2B | 20.4B | 26.4B | 33.9B |
| Cost of Revenue | 775.0M | 3.8B | 4.3B | 7.2B | 7.3B |
| Gross Profit | 2.9B | 12.4B | 16.1B | 19.2B | 26.6B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 2.3B | 11.8B | 16.0B | 19.9B | 24.2B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 2.3B | 11.8B | 16.0B | 19.9B | 24.2B |
| Cost and Expenses | 15.0B | 15.5B | 20.2B | 27.0B | 31.5B |
| Operating Income (EBIT) | 570.0M | 617.0M | 139.0M | (611.0M) | 2.4B |
| Non-Operating | |||||
| Interest Income | 4.0M | 3.0M | 1.0M | 1.6M | 1.4M |
| Interest Expense | 3.0M | 19.0M | 22.0M | 18.8M | 14.9M |
| Net Interest Income | 1.0M | (16.0M) | (21.0M) | (17.2M) | (13.5M) |
| Other Non-Op Income/Expense | 33.0M | (17.0M) | 22.0M | (19.5M) | 158.0M |
| Non-Operating Income (excl Interest) | 33.0M | 12.0M | 48.0M | 23.4M | 174.5M |
| EBT (Pre-Tax Income) | 609.0M | 588.0M | (902.0M) | (659.5M) | 2.6B |
| Income Tax Expense | 200.0M | 116.0M | 581.0M | 74.5M | 1.1B |
| Bottom Line | |||||
| Net Income | 465.0M | 471.0M | (1.5B) | (733.0M) | 1.4B |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 465.0M | 471.0M | (1.5B) | (733.0M) | 1.4B |
| Per Share | |||||
| Basic EPS | ¥53 | ¥54 | (¥170) | (¥84) | ¥163 |
| Diluted EPS | ¥53 | ¥54 | — | — | ¥163 |
| Revenue Per Share | ¥1,786 | ¥1,853 | ¥2,335 | ¥3,027 | ¥3,889 |
| Shares | |||||
| Basic Shares Outstanding | 8.7M | 8.7M | 8.7M | 8.7M | 8.7M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 874.0M | 348.0M | (427.0M) | 2.5B |
| D&A | — | 257.0M | 209.0M | 184.0M | 85.5M |
| EBIT | 570.0M | 617.0M | 139.0M | (611.0M) | 2.4B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jan 1, 2026